Skip to Content
Artificial intelligence

AI could help design better drugs that don’t clash with other medication

February 6, 2020
A pharmacist selects a bottle of medication from shelves and shelves of options.
A pharmacist selects a bottle of medication from shelves and shelves of options.Joe Raedle/Getty

A new system that can predict a proposed drug’s chemical structure could help prevent adverse drug interactions, one of the leading causes of patient death.

Why it matters: According to the FDA, serious adverse drug interactions could kill more than 100,000 hospitalized people in the US every year. But traditional ways of avoiding such interactions during drug development require expensive and laborious physical testing and clinical trials to catalogue all the proposed drug’s possible chemical interactions with existing ones.

How it works: The system takes in two different drugs and generates a prediction for how or whether they will interact. To get there, the researchers first translated the 3D chemical structures of drugs into a character format known as SMILES that could be read by a neural network. The drug melatonin, for example, is represented by “CC(=O)NCCC1=CNc2c1cc(OC)cc2,” while morphine is represented by “CN1CCC23C4OC5=C(O)C=CC(CC1C2C=CC4O)=C35.”

They then trained a neural network on a database of known drug interactions. The resulting system predicts the probability that two drugs will have an adverse interaction and shows the particular parts of the molecule that contributed to that prediction.

The results: When the researchers tested their system on two common drug interaction data sets, it performed better than state-of-the-art results from existing AI systems. The paper, which was led by researchers at health information technology company IQVIA, is being presented at the proceedings of the Association for the Advancement of Artificial Intelligence later this week.

Co-pilot: The new techniques for analyzing chemical data could have many other applications, including drug and material design. “There's just an awful lot of the modern world that depends on chemistry,” says David Cox, the IBM director of the MIT-IBM Watson AI Lab, a member of which coauthored the paper. “There’s tremendous potential for AI to be a copilot for us, augmenting our ability to reason about chemical interactions, properties, and qualities.”

Correction: An earlier version of this article misstated David Cox‘s title as director and SMILES as a new convention. The article has since been updated.

To have more stories like this delivered directly to your inbox, sign up for our Webby-nominated AI newsletter The Algorithm. It's free.

Deep Dive

Artificial intelligence

A Roomba recorded a woman on the toilet. How did screenshots end up on Facebook?

Robot vacuum companies say your images are safe, but a sprawling global supply chain for data from our devices creates risk.

The viral AI avatar app Lensa undressed me—without my consent

My avatars were cartoonishly pornified, while my male colleagues got to be astronauts, explorers, and inventors.

Roomba testers feel misled after intimate images ended up on Facebook

An MIT Technology Review investigation recently revealed how images of a minor and a tester on the toilet ended up on social media. iRobot said it had consent to collect this kind of data from inside homes—but participants say otherwise.

How to spot AI-generated text

The internet is increasingly awash with text written by AI software. We need new tools to detect it.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.